37th Annual Advances in Heart Disease

 

Day 1
06:37

37th Annual Advances in Heart Disease

Results of the COMPASS and VOYAGER PAD Trials: Is Rivaroxaban in Combination with Aspirin More Effective than Aspirin Alone for Secondary Cardiovascular Prevention in Patients with PAD?

FEATURING Mark Creager
  • 842 views
  • February 11, 2021
  • 1
35:08

37th Annual Advances in Heart Disease

Managing Cannabis Use in Patients with Cardiovascular Disease

FEATURING Neal Benowitz, Binh An Phan
  • 447 views
  • February 5, 2021
  • 1
35:57

37th Annual Advances in Heart Disease

Updates in Preoperative Evaluation in Patients Undergoing Non-cardiac Surgery: Review of the ACC/AHA Guidelines, Temporal Trends and Functional Assessment Methods

FEATURING Rachel Eshima Mckay
  • 366 views
  • February 4, 2021
  • 5
39:29

37th Annual Advances in Heart Disease

Contemporary Approach for Managing PAD: What Are the Guideline Recommended Therapies? What Is the Efficacy of Statin Therapy, PCSK9 Inhibitors, Antiplatelet Agents and Anticoagulants?

FEATURING Mark Creager, Binh An Phan
  • 258 views
  • February 4, 2021
  • 2
35:53

37th Annual Advances in Heart Disease

Evaluation of Cryptogenic Strokes: How to Diagnose Them? Should You Use Antiplatelet Agents as First-line Antithrombotic Therapy?

FEATURING Claude Hemphill, Binh An Phan
  • 542 views
  • February 4, 2021
  • 1
26:26

37th Annual Advances in Heart Disease

Cardiac Rehabilitation: How Beneficial Is It? Can Patients Have CR at Home and Online?

FEATURING Alexis Beatty
  • 26 views
  • February 4, 2021
06:48

37th Annual Advances in Heart Disease

Hypertrophic Cardiomyopathy: What Is the Role of Genetic Testing? What Are the Worst Symptoms that Could Be Expected?

FEATURING Peter Ganz, Theodore Abraham
  • 32 views
  • January 29, 2021
35:46

37th Annual Advances in Heart Disease

Lipoprotein(a) and CVD: Do Elevated Lp(a) Levels Contribute to CVD Risk? What Are the Effects of Statins, PCSK9-i, LDL Apheresis and ASOs Therapies?

FEATURING Binh An Phan, Peter Ganz
  • 1,817 views
  • January 29, 2021
  • 16
30:35

37th Annual Advances in Heart Disease

Native Valve Endocarditis: How to Use the Duke Criteria and Echocardiography for the Diagnosis of Endocarditis? What Medical Therapy Is Recommended and When to Perform Surgery?

FEATURING Peter Ganz, Henry Chambers
  • 875 views
  • January 29, 2021
  • 7
42:18

37th Annual Advances in Heart Disease

Myocardial Viability Testing and Coronary Revascularization in Ischemic Cardiomyopathy: PCI, CABG or Medical Therapy?

FEATURING John MacGregor, Peter Ganz
  • 1,930 views
  • January 29, 2021
  • 21
42:59

37th Annual Advances in Heart Disease

Updates in HFpEF Diagnosis and Treatment: Can the Identification of NT-proBNP Levels Be Helpful in Making a Diagnosis? How Effective Is Sacubitril/Valsartan for Treating HFpEF Patients?

FEATURING Scott Solomon
  • 1,113 views
  • January 29, 2021
  • 3
04:19

37th Annual Advances in Heart Disease

What Are the Main Risk Factors that Need to Be Taken Into Account to Prevent HFpEF? How Helpful Is Machine Learning in HFpEF?

FEATURING Scott Solomon, Peter Ganz
  • 19 views
  • January 29, 2021
29:13

37th Annual Advances in Heart Disease

Update on Hypertrophic Cardiomyopathy: How to Use Imaging for Diagnosing and Monitoring the Disease? Should You Treat the Patients Medically or Perform Alcohol Ablation, RF Ablation and Surgical Myectomy?

FEATURING Theodore Abraham
  • 930 views
  • January 29, 2021
  • 12